{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:08:11Z","timestamp":1777558091125,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1378\/chest.128.4.2298","type":"journal-article","created":{"date-parts":[[2005,10,19]],"date-time":"2005-10-19T17:57:43Z","timestamp":1129744663000},"page":"2298-2303","source":"Crossref","is-referenced-by-count":74,"title":["Diagnostic Utility of Serum and Pleural Fluid Carcinoembryonic Antigen, Neuron-Specific Enolase, and Cytokeratin 19 Fragments in Patients With Effusions From Primary Lung Cancer"],"prefix":"10.1016","volume":"128","author":[{"given":"Jin","family":"Hwa Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung","family":"Hyun Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.128.4.2298_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1378\/chest.107.6.1598","article-title":"Diagnosis of pleural effusions: experience with clinical studies, 1986 to 1990","volume":"107","author":"Marel","year":"1995","journal-title":"Chest"},{"key":"10.1378\/chest.128.4.2298_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0002-9610(99)80257-8","article-title":"Diagnosis and management of malignant pleural effusions","volume":"170","author":"Fenton","year":"1995","journal-title":"Am J Surg"},{"key":"10.1378\/chest.128.4.2298_bib3","first-page":"320","article-title":"Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination","volume":"4","author":"Nance","year":"1991","journal-title":"Mod Pathol"},{"key":"10.1378\/chest.128.4.2298_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0025-6196(12)60212-2","article-title":"Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases","volume":"60","author":"Prakash","year":"1985","journal-title":"Mayo Clin Proc"},{"key":"10.1378\/chest.128.4.2298_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0954-6111(08)80089-3","article-title":"Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology","volume":"84","author":"Edmondstone","year":"1990","journal-title":"Respir Med"},{"key":"10.1378\/chest.128.4.2298_bib6","first-page":"108","article-title":"Pleural effusions related to metastatic malignancies","author":"Light","year":"2001"},{"key":"10.1378\/chest.128.4.2298_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1183\/09031936.96.09010017","article-title":"CEA, CA 15\u20133 and CYFRA 21\u20131 in serum and pleural fluid of patients with pleural effusions","volume":"9","author":"Romero","year":"1996","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.128.4.2298_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0009-8981(97)00120-4","article-title":"Utility of tumour markers in the diagnosis of neoplastic pleural effusion","volume":"265","author":"San Jose","year":"1997","journal-title":"Clin Chim Acta"},{"key":"10.1378\/chest.128.4.2298_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/bjc.1998.75","article-title":"Evaluation of pleural CYFRA 21\u20131 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions","volume":"77","author":"Salama","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.128.4.2298_bib10","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y","article-title":"Diagnostic utility of CYFRA 21\u20131, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions","volume":"86","author":"Ferrer","year":"1999","journal-title":"Cancer"},{"key":"10.1378\/chest.128.4.2298_bib11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjc.6690807","article-title":"Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions","volume":"81","author":"Miedouge","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1378\/chest.128.4.2298_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000029458","article-title":"Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion","volume":"67","author":"Riantawan","year":"2000","journal-title":"Respiration"},{"key":"10.1378\/chest.128.4.2298_bib13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-5002(00)00153-7","article-title":"Diagnostic value of CEA, CA 15\u20133, CA 19\u20139, CYFRA 21\u20131, NSE and TSA assay in pleural effusions","volume":"31","author":"Alatas","year":"2001","journal-title":"Lung Cancer"},{"key":"10.1378\/chest.128.4.2298_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0169-5002(01)00474-3","article-title":"CEA and CA 549 in serum and pleural fluid of patients with pleural effusion","volume":"36","author":"Hernandez","year":"2002","journal-title":"Lung Cancer"},{"key":"10.1378\/chest.128.4.2298_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0169-5002(03)00120-X","article-title":"Diagnostic value of CA 549 in pleural fluid: comparison with CEA, CA 15.3 and CA 72.4","volume":"40","author":"Villena","year":"2003","journal-title":"Lung Cancer"},{"key":"10.1378\/chest.128.4.2298_bib16","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1378\/chest.126.6.1757","article-title":"Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15\u20133, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions","volume":"126","author":"Porcel","year":"2004","journal-title":"Chest"},{"key":"10.1378\/chest.128.4.2298_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1183\/09031936.93.01080698","article-title":"Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report","volume":"1","author":"Petterson","year":"1988","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.128.4.2298_bib18","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1378\/chest.95.3.602","article-title":"Pleural fluid neuron-specific enolase: a useful diagnostic marker for small cell lung cancer pleurisy","volume":"95","author":"Shimokata","year":"1989","journal-title":"Chest"},{"key":"10.1378\/chest.128.4.2298_bib19","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000227459","article-title":"Clinical evaluation of CYFRA 21\u20131 in malignant pleural fluids","volume":"52","author":"Satoh","year":"1995","journal-title":"Oncology"},{"key":"10.1378\/chest.128.4.2298_bib20","first-page":"2101","article-title":"Evaluation of CYFRA 21\u20131 in malignant and benign pleural effusions","volume":"16","author":"Toumbis","year":"1996","journal-title":"Anticancer Res"},{"key":"10.1378\/chest.128.4.2298_bib21","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1445-5994.1999.tb00777.x","article-title":"Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21\u20131) in the differentiation of malignant and benign pleural effusions","volume":"29","author":"Lee","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1378\/chest.128.4.2298_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.1440-1843.2001.00332.x","article-title":"Diagnostic utility of CYFRA 21\u20131 in malignant pleural effusion","volume":"6","author":"Dejsomritrutai","year":"2001","journal-title":"Respirology"},{"key":"10.1378\/chest.128.4.2298_bib23","first-page":"87","article-title":"Approach to the patient","author":"Light","year":"2001"},{"key":"10.1378\/chest.128.4.2298_bib24","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<736::AID-CNCR7>3.0.CO;2-C","article-title":"Diagnostic value of CA 72\u20134, carcinoembryonic antigen, CA 15\u20133, and CA 19\u20139 assay in pleural fluid: a study of 207 patients","volume":"78","author":"Villena","year":"1996","journal-title":"Cancer"},{"key":"10.1378\/chest.128.4.2298_bib25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.95.08030407","article-title":"CYFRA 21\u20131 as a tumour marker for bronchogenic carcinoma","volume":"8","author":"Rapellino","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.128.4.2298_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0954-6111(97)90049-4","article-title":"Comparison of cytokeratin fragment 19 (CYFRA 21\u20131), tissue polypeptide antigen (TPA) and carcinocembryonic antigen (CEA) as tumour markers in bronchogenic carcinoma","volume":"91","author":"Huang","year":"1997","journal-title":"Respir Med"},{"key":"10.1378\/chest.128.4.2298_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0959-8049(97)89010-7","article-title":"Diagnostic and prognostic value of Cyfra 21\u20131 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients","volume":"33","author":"Brechot","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1378\/chest.128.4.2298_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1183\/09031936.97.10030603","article-title":"Diagnostic value of SCC, CEA and CYFRA 21\u20131 in lung cancer: a Bayesian analysis","volume":"10","author":"Pastor","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.128.4.2298_bib29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/0959-8049(93)90525-K","article-title":"Improvement of the diagnosis of the cause of a pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels","volume":"13","author":"Menard","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1378\/chest.128.4.2298_bib30","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO;2-U","article-title":"The malignant pleural effusion: a review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients","volume":"56","author":"Johnston","year":"1985","journal-title":"Cancer"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215526354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215526354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T03:42:06Z","timestamp":1706672526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215526354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0012369215526354"],"URL":"https:\/\/doi.org\/10.1378\/chest.128.4.2298","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}